| HOME >> BIOLOGY >> TECHNOLOGY |
even more important today in this challenging environment."
Kubacki concluded, "The Company's balance sheet remains strong with approximately $6.6 million of cash and short-term investments, no long-term debt and over $9.5 million of working capital. Our directors share our confidence in the future of Psychemedics and remain committed to rewarding shareholders and sharing the financial success of the Company with them as we grow. Therefore, we are pleased to declare our 50th consecutive quarterly dividend."
Psychemedics is the world's largest provider of hair testing for drugs of abuse with thousands of corporations relying on the patented Psychemedics drug testing services. Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and six Federal Reserve Banks.
The Psychemedics web site is www.drugtestwithhair.com
Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995: From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties. In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning earnings, earnings per share, revenues, dividends, future business, new accounts, customer base, market share, test volume and sales and marketing strategies) may be "forward looking" statements. Actual results may differ from those stated in any forward-looking statements. Factors that may cause such differences include but are not limited to risks associated with the expansion of the Company's sales and marketing network, development of markets for new products and services offered, the economic health of principal customers of the Company, government regulation, including but not
'/>"/>
| SOURCE Psychemedics Corporation Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Psychemedics Corporation Authorizes A 250,000 Share Stock Repurchase Program
2. Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)
3. NanoBio Corporation Raises $12 Million in Series B Financing
4. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Monoplace Hyperbaric Chambers
5. Newbridge Securities Corporation Forms BioVentures Division
6. Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast
7. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on February 17, 2009
8. Mirixa Corporation and the APhA Foundation Finalize Partnership
9. Mach One Corporation Signs Definitive Agreement to Acquire Ceres Organic Harvest, Inc.
10. ETHEX Corporation Issues Nationwide Voluntary Recall of Products
11. Ther-Rx Corporation Issues Nationwide Voluntary Recall of Products
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |